Navigation Links
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
Date:9/5/2012

SAN DIEGO, Sept. 5, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Morgan Stanley Global Healthcare Conference in New York.   

The live presentation takes place on Wednesday, September 12 at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
5. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
8. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
9. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
10. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
11. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... EarlySense , the market leader in Contact-Free ... recognized medical center and a member of Partners Healthcare, has ... of its Early Detection of Deterioration Project. The facility also ... time to alarms. ... According to the peer-reviewed paper published ...
(Date:3/22/2017)... 22, 2017 FinancialBuzz.com News Commentary ... cannabis industry is strongly contributing to job creation. A ... and reporting for the cannabis industry, projects that by ... a quarter million jobs for American workers. The legal ... 2016, and is projected to grow at a compound ...
(Date:3/22/2017)...  As the world,s leading non-profit dedicated to fighting ... played a role in most therapies used today to ... helping patients with other cancers and serious diseases. Such ... cutting-edge research – more than $1 billion in the ... record-breaking sum of $4.1 million raised at the 30 ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that identifying savings ... Healthcare facilities across the country are always forced to focus on costs ... across the country, an efficient and quick way to estimate savings potential within ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to cure Rett Syndrome, a devastating neurological disorder that afflicts 350,000 individuals worldwide. ... on the X chromosome, and almost exclusively strikes females. Following a normal ...
(Date:3/22/2017)... PA (PRWEB) , ... March 22, 2017 , ... Last ... according to a US Department of Agriculture report. While excess dairy can be ... play a role. Lactose sensitivity is the inability to properly digest lactose, a sugar ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Tyler Hitchcock ... to communities across eastern Texas, is announcing a charity drive in conjunction with ... children and adults. , Consistently a top-rated nonprofit organization for hunger relief, ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... and financial planning assistance to communities throughout central Ohio, is initiating a charity ... Estimates from the Department of Defense and the Veteran's Brain Injury Center conclude ...
Breaking Medicine News(10 mins):